- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Perfusion predicts six-month survival
Results from a prospective study bolster confidence that a negative adenosine perfusion contrast MR test means patients have a good chance of surviving the next six months without major heart problems.
Results from a prospective study bolster confidence that a negative adenosine perfusion contrast MR test means patients have a good chance of surviving the next six months without major heart problems.
Dr. David Hardung from St. Marien Hospital in Bonn, Germany, surveyed the medical experience of 432 patients with negative adenosine stress tests or evidence of minor perfusion deficits involving less than 25% transmural enhancement of the myocardial wall. The event-free survival rate after 267 days was 98.8%. One cardiac death was reported from nonischemic dilated cardiomyopathy. No incidences of myocardial infarction or acute coronary syndrome occurred, but four cases of significant coronary artery disease were identified among 36 patients who underwent coronary angiography in the follow-up period.
Can MRI Have an Impact with Fertility-Sparing Treatments for Endometrial and Cervical Cancers?
January 9th 2025In a literature review that includes insights from recently issued guidelines from multiple European medical societies, researchers discuss the role of magnetic resonance imaging (MRI) in facilitating appropriate patient selection for fertility-sparing treatments to address early-stage endometrial and cervical cancer.
Surveillance Breast MRI Associated with Lower Risks of Advanced Second Breast Cancers
January 8th 2025After propensity score matching in a study of over 3,000 women with a personal history of breast cancer, researchers found that surveillance breast MRI facilitated a 59 percent lower risk in advanced presentations of second breast cancers.
Abbreviated MRI for Hepatocellular Carcinoma: What a New Meta-Analysis Reveals
January 6th 2025For hepatocellular carcinoma screening, a 19-study meta-analysis found the abbreviated MRI sequencing protocol of T2-weighted MRI, diffusion-weighted imaging (DWI) and hepatobiliary phase (HBP) imaging offered 88 percent sensitivity and 93 percent specificity.
New CT and MRI Research Shows Link Between LR-M Lesions and Rapid Progression of Early-Stage HCC
January 2nd 2025Seventy percent of LR-M hepatocellular carcinoma (HCC) cases were associated with rapid growth in comparison to 12.5 percent of LR-4 HCCs and 28.5 percent of LR-4 HCCs, according to a new study.
